Literature DB >> 23457295

Probiotics: properties, examples, and specific applications.

Judith Behnsen1, Elisa Deriu, Martina Sassone-Corsi, Manuela Raffatellu.   

Abstract

Probiotics are beneficial components of the microbiota that have been used for centuries because of the health benefits they confer to the host. Only recently, however, has the contribution of probiotics to modulation of immunological, respiratory, and gastrointestinal functions started to be fully appreciated and scientifically evaluated. Probiotics such as Escherichia coli Nissle 1917 and lactic acid bacteria are currently used to, or have been evaluated for use to, prevent or treat a range of intestinal maladies including inflammatory bowel disease, constipation, and colon cancer. Engineering these natural probiotics to produce immunomodulatory molecules may help to further increase the benefit to the host. In this article, we will discuss some of the mechanisms of action of probiotics as well as advances in the rational design of probiotics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457295      PMCID: PMC3579206          DOI: 10.1101/cshperspect.a010074

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  130 in total

Review 1.  Ecological fitness, genomic islands and bacterial pathogenicity. A Darwinian view of the evolution of microbes.

Authors:  J Hacker; E Carniel
Journal:  EMBO Rep       Date:  2001-05       Impact factor: 8.807

2.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

3.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

4.  Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection.

Authors:  Erin C Garcia; Ariel R Brumbaugh; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

5.  Recommendations for probiotic use-2011 update.

Authors:  Martin H Floch; W Allan Walker; Karen Madsen; Mary Ellen Sanders; George T Macfarlane; Harry J Flint; Levinus A Dieleman; Yehuda Ringel; Stefano Guandalini; Ciaran P Kelly; Lawrence J Brandt
Journal:  J Clin Gastroenterol       Date:  2011-11       Impact factor: 3.062

6.  Short-chain fatty acids in germfree mice and rats.

Authors:  T Høverstad; T Midtvedt
Journal:  J Nutr       Date:  1986-09       Impact factor: 4.798

Review 7.  The battle for iron between bacterial pathogens and their vertebrate hosts.

Authors:  Eric P Skaar
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

8.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

Review 10.  Probiotics: considerations for human health.

Authors:  Mary Ellen Sanders
Journal:  Nutr Rev       Date:  2003-03       Impact factor: 7.110

View more
  74 in total

1.  A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor.

Authors:  J L McCarville; J Dong; A Caminero; M Bermudez-Brito; J Jury; J A Murray; S Duboux; M Steinmann; M Delley; M Tangyu; P Langella; A Mercenier; G Bergonzelli; E F Verdu
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

Review 2.  Production and Biomedical Applications of Probiotic Biosurfactants.

Authors:  Anila Fariq; Ayesha Saeed
Journal:  Curr Microbiol       Date:  2016-01-07       Impact factor: 2.188

3.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

Review 4.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Authors:  Franco Scaldaferri; Viviana Gerardi; Francesca Mangiola; Loris Riccardo Lopetuso; Marco Pizzoferrato; Valentina Petito; Alfredo Papa; Jovana Stojanovic; Andrea Poscia; Giovanni Cammarota; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

5.  Feeding the probiotic Enterococcus faecium strain NCIMB 10415 to piglets specifically reduces the number of Escherichia coli pathotypes that adhere to the gut mucosa.

Authors:  Carmen Bednorz; Sebastian Guenther; Kathrin Oelgeschläger; Bianca Kinnemann; Robert Pieper; Susanne Hartmann; Karsten Tedin; Torsten Semmler; Konrad Neumann; Peter Schierack; Astrid Bethe; Lothar H Wieler
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

6.  From promotion to management: the wide impact of bacteria on cancer and its treatment.

Authors:  Ernesto Perez-Chanona; Christian Jobin
Journal:  Bioessays       Date:  2014-04-22       Impact factor: 4.345

7.  The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients?

Authors:  Mary I Butler; Sabrina Mörkl; Kiran V Sandhu; John F Cryan; Timothy G Dinan
Journal:  Can J Psychiatry       Date:  2019-09-17       Impact factor: 4.356

8.  Development of Bacterial Therapeutics against the Bovine Respiratory Pathogen Mannheimia haemolytica.

Authors:  Samat Amat; Edouard Timsit; Danica Baines; Jay Yanke; Trevor W Alexander
Journal:  Appl Environ Microbiol       Date:  2019-10-16       Impact factor: 4.792

9.  Siderophore-based immunization strategy to inhibit growth of enteric pathogens.

Authors:  Martina Sassone-Corsi; Phoom Chairatana; Tengfei Zheng; Araceli Perez-Lopez; Robert A Edwards; Michael D George; Elizabeth M Nolan; Manuela Raffatellu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 10.  Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.

Authors:  Laura Marinela Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.